The Role of Sex Steroids in the Pathogenesis of Osteoporosis

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Significant bone loss occurs with aging in both men and women, leading to alterations in skeletal microarchitecture and increased fracture incidence. Much work has now significantly enhanced our understanding of the role that sex steroids (primarily estrogen and testosterone) play in the development and progression of osteoporosis in both men and women. In addition to changes in bone mass that occur with aging, changes in bone cross-sectional area also occur in both sexes across skeletal sites. The relationship between diminishing estrogen levels in women caused by ovarian failure and the development of postmenopausal osteoporosis has been recognized for seven decades. It is likely that intrinsic changes occur in osteoblast and perhaps osteoclast lineage cells with aging. These changes, which are likely independent of changes in sex steroids or other hormonal factors, are the focus of ongoing animal and human studies.

Original languageEnglish (US)
Title of host publicationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
Subtitle of host publicationEighth Edition
PublisherWiley Blackwell
Pages367-375
Number of pages9
ISBN (Electronic)9781118453926
ISBN (Print)9781118453889
DOIs
StatePublished - Jul 19 2013

Fingerprint

Osteoporosis
Bone
Aging of materials
Steroids
Bone and Bones
Estrogens
Postmenopausal Osteoporosis
Cell Aging
Osteoblasts
Osteoclasts
Testosterone
Animals
Incidence

Keywords

  • Aging
  • Bone loss
  • Bone mass
  • Osteoporosis
  • Sex steroids

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Drake, M. M., & Khosla, S. (2013). The Role of Sex Steroids in the Pathogenesis of Osteoporosis. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition (pp. 367-375). Wiley Blackwell. https://doi.org/10.1002/9781118453926.ch43

The Role of Sex Steroids in the Pathogenesis of Osteoporosis. / Drake, Matthew M; Khosla, Sundeep.

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, 2013. p. 367-375.

Research output: Chapter in Book/Report/Conference proceedingChapter

Drake, MM & Khosla, S 2013, The Role of Sex Steroids in the Pathogenesis of Osteoporosis. in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, pp. 367-375. https://doi.org/10.1002/9781118453926.ch43
Drake MM, Khosla S. The Role of Sex Steroids in the Pathogenesis of Osteoporosis. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell. 2013. p. 367-375 https://doi.org/10.1002/9781118453926.ch43
Drake, Matthew M ; Khosla, Sundeep. / The Role of Sex Steroids in the Pathogenesis of Osteoporosis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, 2013. pp. 367-375
@inbook{013a9d77e2ee46eabacb178f6e4a3013,
title = "The Role of Sex Steroids in the Pathogenesis of Osteoporosis",
abstract = "Significant bone loss occurs with aging in both men and women, leading to alterations in skeletal microarchitecture and increased fracture incidence. Much work has now significantly enhanced our understanding of the role that sex steroids (primarily estrogen and testosterone) play in the development and progression of osteoporosis in both men and women. In addition to changes in bone mass that occur with aging, changes in bone cross-sectional area also occur in both sexes across skeletal sites. The relationship between diminishing estrogen levels in women caused by ovarian failure and the development of postmenopausal osteoporosis has been recognized for seven decades. It is likely that intrinsic changes occur in osteoblast and perhaps osteoclast lineage cells with aging. These changes, which are likely independent of changes in sex steroids or other hormonal factors, are the focus of ongoing animal and human studies.",
keywords = "Aging, Bone loss, Bone mass, Osteoporosis, Sex steroids",
author = "Drake, {Matthew M} and Sundeep Khosla",
year = "2013",
month = "7",
day = "19",
doi = "10.1002/9781118453926.ch43",
language = "English (US)",
isbn = "9781118453889",
pages = "367--375",
booktitle = "Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - The Role of Sex Steroids in the Pathogenesis of Osteoporosis

AU - Drake, Matthew M

AU - Khosla, Sundeep

PY - 2013/7/19

Y1 - 2013/7/19

N2 - Significant bone loss occurs with aging in both men and women, leading to alterations in skeletal microarchitecture and increased fracture incidence. Much work has now significantly enhanced our understanding of the role that sex steroids (primarily estrogen and testosterone) play in the development and progression of osteoporosis in both men and women. In addition to changes in bone mass that occur with aging, changes in bone cross-sectional area also occur in both sexes across skeletal sites. The relationship between diminishing estrogen levels in women caused by ovarian failure and the development of postmenopausal osteoporosis has been recognized for seven decades. It is likely that intrinsic changes occur in osteoblast and perhaps osteoclast lineage cells with aging. These changes, which are likely independent of changes in sex steroids or other hormonal factors, are the focus of ongoing animal and human studies.

AB - Significant bone loss occurs with aging in both men and women, leading to alterations in skeletal microarchitecture and increased fracture incidence. Much work has now significantly enhanced our understanding of the role that sex steroids (primarily estrogen and testosterone) play in the development and progression of osteoporosis in both men and women. In addition to changes in bone mass that occur with aging, changes in bone cross-sectional area also occur in both sexes across skeletal sites. The relationship between diminishing estrogen levels in women caused by ovarian failure and the development of postmenopausal osteoporosis has been recognized for seven decades. It is likely that intrinsic changes occur in osteoblast and perhaps osteoclast lineage cells with aging. These changes, which are likely independent of changes in sex steroids or other hormonal factors, are the focus of ongoing animal and human studies.

KW - Aging

KW - Bone loss

KW - Bone mass

KW - Osteoporosis

KW - Sex steroids

UR - http://www.scopus.com/inward/record.url?scp=84975158745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975158745&partnerID=8YFLogxK

U2 - 10.1002/9781118453926.ch43

DO - 10.1002/9781118453926.ch43

M3 - Chapter

AN - SCOPUS:84975158745

SN - 9781118453889

SP - 367

EP - 375

BT - Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

PB - Wiley Blackwell

ER -